Emerging Technologies in Continuous IOP Monitoring - Takeaway - MDSpire
Feature

Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.

Share

  • 1

    Traditional tonometry has limitations in continuous IOP monitoring.

  • 2

    Continuous monitoring devices include CLBS and bioMEMS.

  • 3

    CLBS can detect nocturnal IOP fluctuations.

  • 4

    Implantable sensors provide precise long-term monitoring but require surgery.

  • 5

    Proper patient selection is essential for device implantation.

  • 6

    Monitoring must be combined with medical therapy for effective glaucoma management.

  • 7

    Device safety is generally high, with minor side effects reported.

Original Source(s)

Emerging Technologies in Continuous IOP Monitoring

  • by Khushi Saigal, BA, Rachel Chapman, Samantha Goldburg, MD, Mary Qiu, MD,

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.